Literature DB >> 32003459

Inverted urothelial papilloma and urothelial carcinoma with inverted growth are histologically and molecularly distinct entities.

Nima Almassi1, Eugene J Pietzak1, Judy Sarungbam2, Satish K Tickoo2, Victor E Reuter2, David B Solit3,4, Hikmat A Al-Ahmadie2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32003459      PMCID： PMC7424783          DOI： 10.1002/path.5390

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   9.883


× No keyword cloud information.
  6 in total

1.  Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.

Authors:  Sumit Isharwal; Wenhuo Hu; Judy Sarungbam; Ying-Bei Chen; Anuradha Gopalan; Samson W Fine; Satish K Tickoo; Sahussapont J Sirintrapun; Sana Jadallah; Florence L Loo; Eugene J Pietzak; Eugene K Cha; Bernard H Bochner; Michael F Berger; Gopa Iyer; David B Solit; Victor E Reuter; Hikmat Al-Ahmadie
Journal:  J Pathol       Date:  2019-04-22       Impact factor: 7.996

2.  Distinct mutational landscape of inverted urothelial papilloma.

Authors:  Mahmut Akgul; Gregory T MacLennan; Liang Cheng
Journal:  J Pathol       Date:  2019-07-02       Impact factor: 7.996

3.  Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.

Authors:  Eugene J Pietzak; Aditya Bagrodia; Eugene K Cha; Esther N Drill; Gopa Iyer; Sumit Isharwal; Irina Ostrovnaya; Priscilla Baez; Qiang Li; Michael F Berger; Ahmet Zehir; Nikolaus Schultz; Jonathan E Rosenberg; Dean F Bajorin; Guido Dalbagni; Hikmat Al-Ahmadie; David B Solit; Bernard H Bochner
Journal:  Eur Urol       Date:  2017-06-03       Impact factor: 20.096

Review 4.  Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients.

Authors:  Stefano Picozzi; Stefano Casellato; Giorgio Bozzini; Dario Ratti; Alberto Macchi; Barbara Rubino; Gianna Pace; Luca Carmignani
Journal:  Urol Oncol       Date:  2012-04-19       Impact factor: 3.498

5.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

6.  OncoKB: A Precision Oncology Knowledge Base.

Authors:  Debyani Chakravarty; Jianjiong Gao; Sarah M Phillips; Ritika Kundra; Hongxin Zhang; Jiaojiao Wang; Julia E Rudolph; Rona Yaeger; Tara Soumerai; Moriah H Nissan; Matthew T Chang; Sarat Chandarlapaty; Tiffany A Traina; Paul K Paik; Alan L Ho; Feras M Hantash; Andrew Grupe; Shrujal S Baxi; Margaret K Callahan; Alexandra Snyder; Ping Chi; Daniel Danila; Mrinal Gounder; James J Harding; Matthew D Hellmann; Gopa Iyer; Yelena Janjigian; Thomas Kaley; Douglas A Levine; Maeve Lowery; Antonio Omuro; Michael A Postow; Dana Rathkopf; Alexander N Shoushtari; Neerav Shukla; Martin Voss; Ederlinda Paraiso; Ahmet Zehir; Michael F Berger; Barry S Taylor; Leonard B Saltz; Gregory J Riely; Marc Ladanyi; David M Hyman; José Baselga; Paul Sabbatini; David B Solit; Nikolaus Schultz
Journal:  JCO Precis Oncol       Date:  2017-05-16
  6 in total
  1 in total

1.  Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth.

Authors:  Minsun Jung; Cheol Lee; Dohyun Han; Kwangsoo Kim; Sunah Yang; Ilias P Nikas; Kyung Chul Moon; Hyeyoon Kim; Min Ji Song; Bohyun Kim; Hyebin Lee; Han Suk Ryu
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.